Wan Y, Li G, Cui G, Duan S, Chang S
Mol Cancer. 2025; 24(1):74.
PMID: 40069775
PMC: 11895238.
DOI: 10.1186/s12943-025-02263-4.
Liu W, Ni Y, Bai H, Liu X, Shahzad A, Cui K
J Biol Chem. 2025; 301(3):108247.
PMID: 39894218
PMC: 11889594.
DOI: 10.1016/j.jbc.2025.108247.
Cho Y, Tan H, Yang J, Kuah B, Lim N, Fu N
Life Metab. 2025; 4(1):loae040.
PMID: 39872984
PMC: 11749863.
DOI: 10.1093/lifemeta/loae040.
Li B, Zeng T, Chen C, Wu Y, Huang S, Deng J
Funct Integr Genomics. 2025; 25(1):11.
PMID: 39798003
DOI: 10.1007/s10142-024-01521-w.
Abdullah A, Kumbrink J, Liokatis P, Mock A, Abdullah A, Dewenter I
Cancers (Basel). 2025; 17(1.
PMID: 39796677
PMC: 11718909.
DOI: 10.3390/cancers17010048.
Revealing the secrets of Blue Zones.
Ulusu N
Front Pharmacol. 2024; 15:1428111.
PMID: 39726786
PMC: 11669513.
DOI: 10.3389/fphar.2024.1428111.
Role of disulfide death in cancer (Review).
Li X, Zhu D
Oncol Lett. 2024; 29(1):55.
PMID: 39606569
PMC: 11600708.
DOI: 10.3892/ol.2024.14801.
METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma.
Jin X, Lv Y, Bie F, Duan J, Ma C, Dai M
Cell Death Differ. 2024; 32(3):466-479.
PMID: 39472692
PMC: 11894169.
DOI: 10.1038/s41418-024-01406-2.
Identification of a senescence-related transcriptional signature to uncover molecular subtypes and key genes in hepatocellular carcinoma.
He X, Liu F, Gong Q
PLoS One. 2024; 19(10):e0311696.
PMID: 39383169
PMC: 11463828.
DOI: 10.1371/journal.pone.0311696.
O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.
Vasquez Martinez I, Perez-Campos E, Perez-Campos Mayoral L, Cruz Luis H, Pina Canseco M, Zenteno E
Int J Mol Sci. 2024; 25(18).
PMID: 39337387
PMC: 11432004.
DOI: 10.3390/ijms25189896.
Chrysomycin A Reshapes Metabolism and Increases Oxidative Stress to Hinder Glioblastoma Progression.
Liu D, Zhang W, Feng W, Xu S, Feng D, Song F
Mar Drugs. 2024; 22(9).
PMID: 39330272
PMC: 11433325.
DOI: 10.3390/md22090391.
Mitochondrial dysfunction and disulfidptosis co-regulate neuronal cell in neuropathic pain based on bioinformatics analysis.
Ge H, Zhou H, Song L, Tao Y, Hu L
Mol Pain. 2024; 20:17448069241290114.
PMID: 39323309
PMC: 11468000.
DOI: 10.1177/17448069241290114.
Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity.
Tamir T, Chaudhary S, Li A, Trojan S, Flower C, Vo P
bioRxiv. 2024; .
PMID: 39257804
PMC: 11383994.
DOI: 10.1101/2024.08.28.609894.
TP53 mutation-related senescence is an indicator of hepatocellular carcinoma patient outcomes from multiomics profiles.
Chen Y, Zhu Z, Ma T, Zhang L, Chen J, Jiang J
Smart Med. 2024; 2(2):e20230005.
PMID: 39188277
PMC: 11235654.
DOI: 10.1002/SMMD.20230005.
Unveiling the Intricacies of Monoamine Oxidase-A (MAO-A) Inhibition in Colorectal Cancer: Computational Systems Biology, Expression Patterns, and the Anticancer Therapeutic Potential.
Bardaweel S, Al-Salamat H, Hajjo R, Sabbah D, Almutairi S
ACS Omega. 2024; 9(33):35703-35717.
PMID: 39184489
PMC: 11339988.
DOI: 10.1021/acsomega.4c04100.
Analysis of the interlink between glucose-6-phosphate dehydrogenase (G6PD) and lung cancer through multi-omics databases.
Thakor P, Siddiqui M, Patel T
Heliyon. 2024; 10(15):e35158.
PMID: 39165939
PMC: 11334843.
DOI: 10.1016/j.heliyon.2024.e35158.
An Oxidative Stress-Related Prognostic Signature Predicts Treatment Response and Outcomes for Hepatocellular Carcinoma After Transarterial Chemoembolization.
Ma H, Yu T, Li Z, Zhang L, Chen R, Ren Z
J Hepatocell Carcinoma. 2024; 11:1569-1580.
PMID: 39156675
PMC: 11330244.
DOI: 10.2147/JHC.S465592.
Development and Validation of a Carbohydrate Metabolism-Related Model for Predicting Prognosis and Immune Landscape in Hepatocellular Carcinoma Patients.
Huang H, Zhong P, Li P, Peng S, Ding X, Cai X
Curr Med Sci. 2024; 44(4):771-788.
PMID: 39096475
DOI: 10.1007/s11596-024-2886-y.
Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy.
Nakamura M, Magara T, Yoshimitsu M, Kano S, Kato H, Yokota K
J Immunother Cancer. 2024; 12(7).
PMID: 39089738
PMC: 11293396.
DOI: 10.1136/jitc-2023-008441.
The Effect of Neuronal CoQ Deficiency and Mitochondrial Dysfunction on a Rotenone-Induced Neuronal Cell Model of Parkinson's Disease.
Millichap L, Turton N, Damiani E, Marcheggiani F, Orlando P, Silvestri S
Int J Mol Sci. 2024; 25(12).
PMID: 38928331
PMC: 11204355.
DOI: 10.3390/ijms25126622.